OVERVIEW
Exploring the treatment of disease through a comprehensive understanding of sugars
Momenta Pharmaceuticals, Inc. is a biotechnology company working to revolutionize medicine by unlocking the science of sugars and complex biomolecules.
Our focus is to capitalize on the commercial application of our broad technology platform and to create innovative therapies with near- and long-term potential that will benefit patients and build value for our shareholders.
You cannot view all of the content in this section because JavaScript is disabled on your browser and/or you need to upgrade your Flash Player.
Leading the way — accelerated by innovative technology
We have demonstrated unparalleled leadership in the burgeoning field of complex sugars through the development of a comprehensive, proprietary technology platform that allows us to achieve a greater understanding of the roles that complex sugars and similar complex mixture compounds play in cellular function, disease and drug action.
Creating broad product applications
Our technology platform enables the thorough characterization of sugar sequences that are found on human cells and proteins, as well as in complex drugs. Since the configuration and structure of sugars are instrumental to mechanisms of diseases and drug action, we are able to gain valuable insight into complex biological processes by leveraging our understanding of sugar structure and relating it to activity.
Understanding sugars with such depth has given us multiple product opportunities. We are currently using our in-depth knowledge of sugars to:
- Develop technology-enabled generic versions of complex drugs that historically have been difficult to duplicate
- Engineer improved versions of currently marketed drugs that contain sugars
- Create new sugar-based drugs based on the novel biology of sugars